retatrutide clinical status

retatrutide clinical status A New Obesity Drug Delivered Surgery-Level Weight Loss in Trials Retatrutide Results: 28.3% Weight Loss

Name: retatrutide clinical status A New Obesity Drug Delivered Surgery-Level Weight Loss in Trials Retatrutide Results: 28.3% Weight Loss
Brand: actil.am
SKU: 15225935938
Price: 22.36 USD
Availability: InStock
Rating: 4.0252 (19 reviews)

SKU: 15225935938

4.0

USD22.36 USD58.36

Pay in 4 interest-free payments of $5.59 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

One in vitro study on human somatic cells confirmed the telomerase-inducing activity of epithalon

It remains an investigational compound, and its use in clinical settings is considered off-label

Additionally, we showed that etoposide , a topoisomerase II inhibitor that restrains DNA replication, effectively inhibits proliferation of NKX21 overexpressing cells